Gene Mutations and Cell Maturity Identified as Key Factors in Acute Myeloid Leukemia Treatment Resistance
2 Articles
2 Articles
Gene mutations and cell maturity identified as key factors in acute myeloid leukemia treatment resistance
An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn't work for everyone. The findings could help doctors better match patients with the therapies most likely to work for them.
New Study Reveals Why Common Leukemia Treatments Fail in Some Patients
An international study led by the University of Colorado Cancer Center has uncovered why a widely used treatment for acute myeloid leukemia (AML) doesn’t work for everyone. The findings could help doctors better match patients with the therapies most likely to work for them.
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage